Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels

Tissue Engineering - Part A

Volumn 17, Issue 13-14, 2011, Pages 1891-1899

  Wirz, Simone ^a   Dietrich, Maren ^a   Flanagan, Thomas C ^b   Bokermann, Gudrun ^a   Wagner, Wolfgang ^a   Schmitz Rode, Thomas ^a   Jockenhoevel, Stefan ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; COLLAGEN; FLOW CYTOMETRY; GELS; PEPTIDES; PLASMA (HUMAN); PLASMAS; SCAFFOLDS (BIOLOGY); SYNCHROTRONS; TISSUE;

COLLAGEN SYNTHESIS; EXTRACELLULAR MATRICES; FIBRIN GELS; FIBRIN-BASED SCAFFOLDS; GROWTH FACTOR; HUMAN UMBILICAL CORD; PLATELET-DERIVED GROWTH FACTORS; PLATELET-RICH PLASMA; POSITIVE EFFECTS; PRODUCTION PROCESS; PROLIFERATION RATE; PROLONGED RELEASE; SMOOTH MUSCLE CELLS; TISSUE DEVELOPMENT;

PLATELETS;

COLLAGEN; FIBRIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET-DERIVED GROWTH FACTOR AB;

ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GEL; HUMAN; METABOLISM; METHODOLOGY; SMOOTH MUSCLE FIBER; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; UMBILICAL ARTERY;

CELL PROLIFERATION; COLLAGEN; FIBRIN; GELS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TISSUE ENGINEERING; UMBILICAL ARTERIES;

EID: 79959555929     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0610     Document Type: Article

References (33)

1. Flanagan, T. C., and Pandit, A. Living artificial heart valve alternatives: a review. Eur Cell Mater 6, 28, 2003.
2. Vacanti, C. A. History of tissue engineering and a glimpse into its future. Tissue Eng 12, 1137, 2006.
3. Jockenhoevel, S., Chalabi, K., Sachweh, J. S., Groesdonk, H. V., Demircan, L., Grossmann, M., et al. Tissue engineering: complete autologous valve conduit-a new moulding technique. Thorac Cardiovasc Surg 49, 287, 2001.
4. Cholewinski, E., Dietrich, M., Flanagan, T. C., Schmitz-Rode, T., and Jockenhoevel, S. Tranexamic acid-an Alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 15, 3645, 2009.
5. Jockenhoevel, S., Zund, G., Hoerstrup, S. P., Chalabi, K., Sachweh, J. S., Demircan, L., et al. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19, 424, 2001.
6. Flanagan, T. C., Sachweh, J., Frese, J., Schnoering, H., Gronloh, N., Koch, S., et al. In vivo remodelling and structural characterisation of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
7. Ross, R., Raines, E. W., and Bowen-Pope, D. F. The biology of platelet-derived growth factor. Cell 46, 155, 1986.
8. Cianciolo, G., Stefoni, S., Zanchelli, F., Iannelli, S., Coli, L., Borgnino, L. C., et al. PDGF-AB release during and after haemodialysis procedure. Nephrol Dial Transplant 14, 2413, 1999.
9. Claesson-Welsh, L. Mechanism of action of platelet-derived growth factor. Int J Biochem Cell Biol 28, 373, 1996.
10. Witte, L. D., Kaplan, K. L., Nossel, H. L., Lages, B. A., Weiss, H. J., and Goodman, D. S. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 42, 402, 1978.
11. Borzini, P., and Mazzucco, I. Platelet rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biological point of view? ISBT Sci Ser 2, 272, 2007.
12. Marx, R. E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62, 489, 2004.
13. Marx, R. E., Carlson, E. R., Eichstaedt, R. M., Schimmele, S. R., Strauss, J. E., and Georgeff, K. R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
14. Whitman, D. H., Berry, R. L., and Green, D. M. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55, 1294, 1997.
15. Rozman, P., and Bolta, Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 16, 156, 2007.
16. Rughetti, A., Giusti, I., D'Ascenzo, S., Leocata, P., Carta, G., Pavan, A., et al. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus 6, 12, 2008.
17. Reddy, G. K., and Enwemeka, C. S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29, 225, 1996.
18. Horn, P., Bokermann, G., Cholewa, D., Bork, S., Walenda, T., Koch, C., et al. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12, 888, 2010.
19. Pesonen, K., Viinikka, L., Myllyla, G., Kiuru, J., and Perheentupa, J. Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets. J Clin Endocrinol Metab 68, 486, 1989.
20. Sekido, Y., Morishima, Y., and Ohya, K. Activity of plateletderived growth factor (PDGF) in platelet concentrates and cryopreserved platelets determined by PDGF bioassay. Vox Sang 52, 27, 1987.
21. Su, C. Y., Kuo, Y. P., Nieh, H. L., Tseng, Y. H., and Burnouf, T. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 48, 2414, 2008.
22. De Donatis, A., Comito, G., Buricchi, F., Vinci, M. C., Parenti, A., Caselli, A., et al. Proliferation versus migration in plateletderived growth factor signaling: the key role of endocytosis. J Biol Chem 283, 19948, 2008.
23. Greiling, D., and Clark, R. A. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110(Pt 7), 861, 1997.
24. Kohler, N., and Lipton, A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87, 297, 1974.
25. Heldin, C. H., and Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79, 1283, 1999.
26. Leroy, E. C., Kaplan, A., Udenfriend, S., and Sjoerdsma, A. A hydroxyproline-containing, collagen-like protein in plasma and a procedure for its assay. J Biol Chem 239, 3350, 1964.
27. Murguia, M. J., Vailas, A., Mandelbaum, B., Norton, J., Hodgdon, J., Goforth, H., et al. Elevated plasma hydroxyproline. 1. Am J Sports Med 16, 660, 1988.
28. Ozturk, I. C., Batcioglu, K., Karatas, F., Hazneci, E., and Genc, M. Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian J Dermatol 53, 106, 2008.
29. Edwards, C. A., and O'Brien, W. D., Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104, 161, 1980.
30. Blumenkrantz, N., Calamera, J. C., Lavieri, J. C., and Mancini, R. E. Ascorbic acid and metabolically related substances in normal and pathological human semen. Fertil Steril 18, 801, 1967.
31. Mill, S., Ware, J. A., and Kent, K. C. Transforming growth factor-β inhibits vascular smooth muscle growth and migration. Surgery 114, 464, 1993.
32. Grainger, D. J., Kemp, P. R., Witchell, C. M., Weissberg, P. L., and Metcalfe, J. C. Transforming growth factor β decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem J 299, 227, 1994.
33. Halloran, B. G., Prorok, G. D., So, B. J., and Baxter, B. T. Transforming growth factor-β inbibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner. Am J Surg 170, 193, 1995.